IDEAYA Biosciences (IDYA) 8-K Summary
Date: November 4, 2025
IDEAYA Biosciences filed this Form 8-K primarily to announce its financial results for the third quarter ended September 30, 2025.
- Key Action: Furnishing of Q3 2025 earnings press release (Exhibit 99.1).
- Investor Note: Specific financial metrics (revenue, cash, profitability, guidance) are contained within Exhibit 99.1 and are not detailed in the 8-K body.
- Regulatory Status: Results are furnished, not deemed “filed” under Section 18 of the Exchange Act.
...Management certification provided b